EditorialThreading the Needle: Individualized Monitoring Guides the Transition From Cytomegalovirus Prophylaxis to Primary Immune Response in a Face Transplant Recipient
References (11)
Infection in organ transplantation
Am J Transplant
(2017)- et al.
New therapies for human cytomegalovirus infections
Antiviral Res
(2018) - et al.
Application of a new paradigm for cytomegalovirus disease prevention in Mayo Clinic's first face transplantation
Mayo Clin Proc
(2019) - et al.
Antibody-mediated rejection of the lung: a consensus report of the International Society for Heart and Lung Transplantation
J Heart Lung Transplant
(2016) - et al.
CD4+CD28− T-cell expansions in ANCA-associated vasculitis and association with arterial stiffness: baseline data from a randomised controlled trial
Lancet
(2015)
There are more references available in the full text version of this article.
Cited by (1)
Cytomegalovirus in solid organ transplant recipients: Clinical updates, challenges and future directions
2020, Current Pharmaceutical Design
See also page 166
Grant Support: The work was supported by grant funding (M.D.G.) from Science Foundation Ireland (CÚRAM Research Centre; grant no. 13/RC/2073), the European Commission (VISICORT [EU Framework 7 grant no. 602470] and NEPHSTROM [EU Horizon 2020 consortium grant no. 634086]), and the European Regional Development Fund.
Potential Competing Interests: Dr Griffin has received honoraria and travel and accommodation costs for attendance at grant review meetings from the American Society of Nephrology and the National Institutes of Health; receives salary for full-time employment from the National University of Ireland Galway and HSE West; and research grants from Science Foundation Ireland and European Commission.
©?2018 Mayo Foundation for Medical Education and Research